Related Experiment Videos

Adverse cardiac events in ICU patients with presumptive antidepressant overdose

C A Arranto1, C Mueller, P R Hunziker

  • 1Division of Intensive Care, Basel University Hospital, Switzerland. Christian.Arranto@stud.unibas.ch

Swiss Medical Weekly
|December 4, 2003
PubMed

Insights

Antidepressant overdose patients frequently have mixed drug ingestions. Adverse cardiac events can occur even with normal initial ECGs, highlighting the need for careful monitoring in intensive care units.

Area of Science:

  • Emergency Medicine
  • Clinical Toxicology
  • Cardiology

Background:

  • Antidepressants are a leading cause of poison-related intensive care unit admissions.
  • Previous studies suggested normal QRS intervals (<0.1s) on ECGs within six hours could rule out cardiac events in cyclic antidepressant intoxication.
  • Prospective data on cardiac events and ECG criteria in presumed antidepressant overdose are limited.

Purpose of the Study:

  • To evaluate ingested substances, cardiac events, and electrocardiogram (ECG) findings in intensive care unit (ICU) patients with suspected antidepressant overdose.
  • To assess the predictive value of ECG criteria in this patient population.

Main Methods:

  • Prospective enrollment and follow-up of 103 consecutive ICU patients with a presumptive diagnosis of antidepressant overdose.
  • Monitoring for arrhythmias, mortality, and ICU length of stay.
  • Analysis of ingested drugs and ECG parameters, including QRS interval.

Main Results:

  • Mixed drug intoxication was prevalent, found in 64% of patients.
  • Tricyclic antidepressants (85%) and serotonin-reuptake inhibitors (24%) were common.
  • 15% of patients experienced arrhythmias, and 3% died. Adverse cardiac events occurred in patients with both normal and prolonged QRS intervals at presentation.

Conclusions:

  • Most ICU patients with suspected antidepressant overdose present with mixed ingestions.
  • There is a significant risk of adverse cardiac events, irrespective of initial ECG findings within the first six hours.
  • Standard ECG criteria may not reliably exclude cardiac complications in all cases of antidepressant overdose.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...